Clicky

Botanix Pharmaceuticals Ltd  (BOT)

Description: Botanix Pharmaceuticals Limited, formerly Bone Medical Limited, is a pharmaceutical company. The Company focuses on developing medical dermatology products for dermatologists and their patients. Its segments include Research & Development and Corporate. The Company's products and pipeline products are all based on drug delivery technology known as Permetrex, which helps solve the challenge of delivering active pharmaceutical ingredients across the skin. The Company's products, which are under development, are focused on modulating the body's endocannabinoid system of receptors which regulates skin function, growth and renewal. Its product pipeline includes BTX1503, BTX1308 and BTX1204. Its BTX1503 is a transdermal gel formulation used for the treatment of serious acne in adults and teenagers. Its BTX1308 is a transdermal gel formulation used for the treatment of plaque psoriasis. Its BTX1204 is a transdermal gel formation used for the treatment of atopic dermititis.


Keywords: Medicine Pharmaceutical Health Sciences Pharmacology Active Pharmaceutical Ingredients Psoriasis Drug Delivery Dermatology Acne Transdermal Plaque Psoriasis Transdermal Patch Drug Delivery Technology Amcinonide Serious Acne

Home Page: www.botanixpharma.com

BOT Technical Analysis

D2, 661 Newcastle Street
Leederville, WA 6007
Australia
Phone: 61 8 6555 2945


Officers

Name Title
Mr. Vincent P. Ippolito MD & Exec. Chairman
Dr. Howie McKibbon Chief Operating Officer
Dr. Henry William Bosch BA, Ph.D. Chief Scientific Officer & Exec. Director
Mr. Matthew Callahan L.L.B., M.B.A., MBA LLB Exec. Director
Dr. Clarence L. Young M.D. Chief Medical Officer
Ms. Lynda Berne Head of Commercial
Dr. Jack Hoblitzell Ph.D. Sr. VP of Pharmaceutical Devel.
Dr. Patricia S. Walker M.D., Ph.D. Chief Medical Adviser
Mr. Simon Robertson C.A., B.Bus, M Appl. Fin, CA Company Sec.

Exchange: AU

Country: AU

Currency: Australian Dollar (A$)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 8.6845
Price-to-Sales TTM: 24.57
IPO Date:
Fiscal Year End: June
Full Time Employees: 11
Back to stocks